Table 3.
The role and mechanisms of macrophage polarization in viral hepatitis.
| Regulation Factor | Research objects | Macrophage polarization | Mechanisms | Year and Country | Reference |
|---|---|---|---|---|---|
| Alleviating hepatotropic virus infection | |||||
| Scavenger receptor-AI | Mice, cells | M2↑ | MerTK↑, mTOR pathway↓ | 2017, America | (118) |
| Alleviating HBV infection | |||||
| Hepatitis B Core Antigen | Patient samples, cells | M2↓ | TLR2/NF-κB pathway↑; STAT6↓ | 2020, China | (109) |
| HBV-miR-3 | Patient samples, cells | M1↑ | SOCS5↓; JAK/STA T signaling pathway↑ | 2020, China | (110) |
| Aggravating HCV infection | |||||
| HCV antigens | Patient samples, cells | M1↓ | A20/A20-binding inhibitor of NF-κB binding protein↑; NF-κB signaling↓ | 2015, China | (119) |
| HCV core protein | Patient samples, cells | M1↓; M2↓ | TLR2 signaling↑; STAT1↓, STAT3↓ | 2016, China | (116) |
| HCV single-stranded RNA | Patient samples, cells | M2↑ | TLR7/8 signaling↑ | 2017, America | (120) |
| HCV E2 envelope glycoprotein | Cells | M2↑ | STAT1↓; STAT3↑ | 2019, America | (121) |